What is Delasco?
Founded in 1980 by a dermatologist, Delasco has evolved into a premier manufacturer and distributor of essential dermatology equipment and supplies. The company maintains a robust portfolio of over 5,000 cost-effective products, catering to the precise needs of more than 7,000 care providers. Its market position is defined by a long-standing commitment to clinical excellence and supply chain reliability, bridging the gap between complex dermatological requirements and practical, high-quality medical solutions. Through its dual role as both a manufacturer and a global distributor, Delasco serves as a critical infrastructure partner for hospitals, university medical centers, and private clinics.
How much funding has Delasco raised?
Delasco has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Delasco
PPP
Public-Private Partnership
What's next for Delasco?
With this late-stage capital, Delasco is positioned to accelerate its strategic initiatives, likely focusing on the expansion of its manufacturing capabilities and the optimization of its global distribution network. As the dermatology sector continues to demand higher precision and cost-efficiency, the company is expected to leverage this investment to integrate advanced supply chain technologies and potentially broaden its product offerings. The focus remains on maintaining its competitive edge in a specialized market, ensuring that the firm continues to support optimal patient outcomes through reliable, high-volume supply delivery. Future growth will likely be characterized by sustained operational scaling and the strengthening of its institutional partnerships.
See full Delasco company page
